Goldman Sachs Future Health Care Equity ETF (GDOC)
ARCA ARCA Primary Summary
GDOC Chart
Healthcare Equity ETF (GDOC) Hits Fresh 52-Week High
GDOC hits a 52-week high as aging demographics, tech advances and strength from top holding LLY fuel momentum.
How Biotech ETF GDOC Is Sending a Red-Hot Buy Signal
Biotech investing may not be the most obvious place for investors to look right now, but factors may be turning in the category's favor. Multiple rate cuts in the back half of 2025 and a friendlier regulatory regime may position biotech investing as a shrewd option to end the year.
Are Biotech ETFs Poised for a Surge? This Stock May Hold the Key
Is now the time to consider biotech ETFs? The stars may be aligning for investing in biotech as 2025 draws to a closer, with ETFs a key route into the space.
Goldman Sachs Future Health Care Equity ETF (GDOC) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Goldman Sachs Future Health Care Equity ETF ever had a stock split?
Goldman Sachs Future Health Care Equity ETF Profile
| ARCA Exchange | US Country |
Overview
The fund is designed specifically for investing in the dynamic and innovative sector of healthcare, focusing majorly on equity investments within both U.S. and international health care companies. It emphasizes on dedicating at least 80% of its assets toward investments that directly contribute to the advancement of health care, leveraging borrowings for this purpose when required. The strategy revolves around pinpointing companies that are at the forefront of health care innovation—ranging from genomics and precision medicine to technology-enhanced medical procedures and digital health solutions. It operates with a non-diversified investment approach, concentrating its resources on a select group of companies that align with its vision of transforming health care through innovation.
Products and Services
The fund's investment philosophy and strategic focus manifest in its targeted selection of products and services including:
- Equity Investments in Health Care Companies: The core of its portfolio, the fund invests in a variety of health care companies that are instrumental in bringing innovative solutions to market, in both the U.S. and internationally. This encompasses a broad spectrum from pharmaceutical giants to biotech startups, all unified by their role in advancing health care.
- Genomics: A key thematic area of investment is in companies involved in genomics. These entities are pioneering efforts to understand and manipulate the genetic codes underlying health and diseases, aiming to offer groundbreaking treatments and diagnostic tools through genetic insights.
- Precision Medicine: Investments in precision medicine reflect the fund's commitment to supporting the development of treatments and therapies tailored to individual genetic profiles, lifestyle, and environment. This approach seeks to optimize healthcare outcomes by ensuring treatments are as effective as possible on a personalized level.
- Technology-enabled Procedures: Recognizing the transformative impact of technology on medical procedures, the fund invests in companies that are leading the way in integrating cutting-edge technologies such as robotic surgery, AI-driven diagnostics, and telemedicine into healthcare practices, enhancing both the efficacy and efficiency of medical care.
- Digital Healthcare: The fund is keen on advancing digital healthcare solutions, supporting companies that leverage digital platforms, software, and services to revolutionize how health care is delivered and experienced. This includes telehealth services, electronic health records, and wearable health technology, all aimed at making health care more accessible, more manageable, and more personalized.
